Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study.
Identifieur interne : 002D51 ( Ncbi/Merge ); précédent : 002D50; suivant : 002D52Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study.
Auteurs : Wings T Y. Loo [Hong Kong] ; L J Jin ; Mary N B. Cheung ; Louis W C. Chow ; Min WangSource :
- Expert opinion on investigational drugs [ 1744-7658 ] ; 2010.
Descripteurs français
- KwdFr :
- Absorptiométrie photonique, Adulte d'âge moyen, Association thérapeutique, Bouche édentée (), Chine, Cyclophosphamide (administration et posologie), Densité osseuse (), Doxorubicine (administration et posologie), Essayage de prothèse (), Facteurs temps, Femelle, Fluorouracil (administration et posologie), Hanche (anatomopathologie), Humains, Mandibule (anatomopathologie), Ostéoporose (), Ostéoporose (diagnostic), Prothèse dentaire complète, Protocoles de polychimiothérapie antinéoplasique (effets indésirables), Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Résorption osseuse (), Sujet âgé, Tumeurs du sein (), Tumeurs du sein (traitement médicamenteux), Études cas-témoins, Études de suivi, Études prospectives.
- MESH :
- administration et posologie : Cyclophosphamide, Doxorubicine, Fluorouracil.
- anatomopathologie : Hanche, Mandibule.
- diagnostic : Ostéoporose.
- effets indésirables : Protocoles de polychimiothérapie antinéoplasique.
- traitement médicamenteux : Tumeurs du sein.
- usage thérapeutique : Protocoles de polychimiothérapie antinéoplasique.
- Absorptiométrie photonique, Adulte d'âge moyen, Association thérapeutique, Bouche édentée, Chine, Densité osseuse, Essayage de prothèse, Facteurs temps, Femelle, Humains, Ostéoporose, Prothèse dentaire complète, Résorption osseuse, Sujet âgé, Tumeurs du sein, Études cas-témoins, Études de suivi, Études prospectives.
- Wicri :
- geographic : République populaire de Chine.
English descriptors
- KwdEn :
- Absorptiometry, Photon, Aged, Antineoplastic Combined Chemotherapy Protocols (adverse effects), Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Bone Density (drug effects), Bone Resorption (chemically induced), Breast Neoplasms (drug therapy), Breast Neoplasms (surgery), Case-Control Studies, China, Combined Modality Therapy, Cyclophosphamide (administration & dosage), Denture, Complete, Doxorubicin (administration & dosage), Female, Fluorouracil (administration & dosage), Follow-Up Studies, Hip (pathology), Humans, Mandible (pathology), Middle Aged, Mouth, Edentulous (complications), Osteoporosis (chemically induced), Osteoporosis (diagnosis), Prospective Studies, Prosthesis Fitting (methods), Time Factors.
- MESH :
- chemical , administration & dosage : Cyclophosphamide, Doxorubicin, Fluorouracil.
- geographic : China.
- adverse effects : Antineoplastic Combined Chemotherapy Protocols.
- chemically induced : Bone Resorption, Osteoporosis.
- complications : Mouth, Edentulous.
- diagnosis : Osteoporosis.
- drug effects : Bone Density.
- drug therapy : Breast Neoplasms.
- methods : Prosthesis Fitting.
- pathology : Hip, Mandible.
- surgery : Breast Neoplasms.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- Absorptiometry, Photon, Aged, Case-Control Studies, Combined Modality Therapy, Denture, Complete, Female, Follow-Up Studies, Humans, Middle Aged, Prospective Studies, Time Factors.
Abstract
Osteoporosis is of concern in breast cancer patients who are undergoing chemotherapy. This study compared the bone mineral density (BMD) index of the mandible and hip hinge between patients who were undergoing chemotherapy or breast cancer, and fully edentulous Chinese patients without cancer over a period of 5 years.
DOI: 10.1517/13543781003727065
PubMed: 20374022
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001988
- to stream PubMed, to step Curation: 001988
- to stream PubMed, to step Checkpoint: 001988
Links to Exploration step
pubmed:20374022Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study.</title><author><name sortKey="Loo, Wings T Y" sort="Loo, Wings T Y" uniqKey="Loo W" first="Wings T Y" last="Loo">Wings T Y. Loo</name><affiliation wicri:level="1"><nlm:affiliation>The University Hong Kong, Hong Kong.</nlm:affiliation><country xml:lang="fr">Hong Kong</country><wicri:regionArea>The University Hong Kong</wicri:regionArea></affiliation></author><author><name sortKey="Jin, L J" sort="Jin, L J" uniqKey="Jin L" first="L J" last="Jin">L J Jin</name></author><author><name sortKey="Cheung, Mary N B" sort="Cheung, Mary N B" uniqKey="Cheung M" first="Mary N B" last="Cheung">Mary N B. Cheung</name></author><author><name sortKey="Chow, Louis W C" sort="Chow, Louis W C" uniqKey="Chow L" first="Louis W C" last="Chow">Louis W C. Chow</name></author><author><name sortKey="Wang, Min" sort="Wang, Min" uniqKey="Wang M" first="Min" last="Wang">Min Wang</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20374022</idno><idno type="pmid">20374022</idno><idno type="doi">10.1517/13543781003727065</idno><idno type="wicri:Area/PubMed/Corpus">001988</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001988</idno><idno type="wicri:Area/PubMed/Curation">001988</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001988</idno><idno type="wicri:Area/PubMed/Checkpoint">001988</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001988</idno><idno type="wicri:Area/Ncbi/Merge">002D51</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study.</title><author><name sortKey="Loo, Wings T Y" sort="Loo, Wings T Y" uniqKey="Loo W" first="Wings T Y" last="Loo">Wings T Y. Loo</name><affiliation wicri:level="1"><nlm:affiliation>The University Hong Kong, Hong Kong.</nlm:affiliation><country xml:lang="fr">Hong Kong</country><wicri:regionArea>The University Hong Kong</wicri:regionArea></affiliation></author><author><name sortKey="Jin, L J" sort="Jin, L J" uniqKey="Jin L" first="L J" last="Jin">L J Jin</name></author><author><name sortKey="Cheung, Mary N B" sort="Cheung, Mary N B" uniqKey="Cheung M" first="Mary N B" last="Cheung">Mary N B. Cheung</name></author><author><name sortKey="Chow, Louis W C" sort="Chow, Louis W C" uniqKey="Chow L" first="Louis W C" last="Chow">Louis W C. Chow</name></author><author><name sortKey="Wang, Min" sort="Wang, Min" uniqKey="Wang M" first="Min" last="Wang">Min Wang</name></author></analytic><series><title level="j">Expert opinion on investigational drugs</title><idno type="eISSN">1744-7658</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Absorptiometry, Photon</term><term>Aged</term><term>Antineoplastic Combined Chemotherapy Protocols (adverse effects)</term><term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term><term>Bone Density (drug effects)</term><term>Bone Resorption (chemically induced)</term><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (surgery)</term><term>Case-Control Studies</term><term>China</term><term>Combined Modality Therapy</term><term>Cyclophosphamide (administration & dosage)</term><term>Denture, Complete</term><term>Doxorubicin (administration & dosage)</term><term>Female</term><term>Fluorouracil (administration & dosage)</term><term>Follow-Up Studies</term><term>Hip (pathology)</term><term>Humans</term><term>Mandible (pathology)</term><term>Middle Aged</term><term>Mouth, Edentulous (complications)</term><term>Osteoporosis (chemically induced)</term><term>Osteoporosis (diagnosis)</term><term>Prospective Studies</term><term>Prosthesis Fitting (methods)</term><term>Time Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Absorptiométrie photonique</term><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Bouche édentée ()</term><term>Chine</term><term>Cyclophosphamide (administration et posologie)</term><term>Densité osseuse ()</term><term>Doxorubicine (administration et posologie)</term><term>Essayage de prothèse ()</term><term>Facteurs temps</term><term>Femelle</term><term>Fluorouracil (administration et posologie)</term><term>Hanche (anatomopathologie)</term><term>Humains</term><term>Mandibule (anatomopathologie)</term><term>Ostéoporose ()</term><term>Ostéoporose (diagnostic)</term><term>Prothèse dentaire complète</term><term>Protocoles de polychimiothérapie antinéoplasique (effets indésirables)</term><term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term><term>Résorption osseuse ()</term><term>Sujet âgé</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (traitement médicamenteux)</term><term>Études cas-témoins</term><term>Études de suivi</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cyclophosphamide</term><term>Doxorubicin</term><term>Fluorouracil</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Cyclophosphamide</term><term>Doxorubicine</term><term>Fluorouracil</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Hanche</term><term>Mandibule</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Bone Resorption</term><term>Osteoporosis</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Mouth, Edentulous</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Osteoporosis</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Ostéoporose</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Bone Density</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Prosthesis Fitting</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Hip</term><term>Mandible</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Absorptiometry, Photon</term><term>Aged</term><term>Case-Control Studies</term><term>Combined Modality Therapy</term><term>Denture, Complete</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Middle Aged</term><term>Prospective Studies</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Absorptiométrie photonique</term><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Bouche édentée</term><term>Chine</term><term>Densité osseuse</term><term>Essayage de prothèse</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Ostéoporose</term><term>Prothèse dentaire complète</term><term>Résorption osseuse</term><term>Sujet âgé</term><term>Tumeurs du sein</term><term>Études cas-témoins</term><term>Études de suivi</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Osteoporosis is of concern in breast cancer patients who are undergoing chemotherapy. This study compared the bone mineral density (BMD) index of the mandible and hip hinge between patients who were undergoing chemotherapy or breast cancer, and fully edentulous Chinese patients without cancer over a period of 5 years.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20374022</PMID><DateCompleted><Year>2010</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1744-7658</ISSN><JournalIssue CitedMedium="Internet"><Volume>19 Suppl 1</Volume><PubDate><Year>2010</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Expert opinion on investigational drugs</Title><ISOAbbreviation>Expert Opin Investig Drugs</ISOAbbreviation></Journal><ArticleTitle>Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study.</ArticleTitle><Pagination><MedlinePgn>S109-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1517/13543781003727065</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Osteoporosis is of concern in breast cancer patients who are undergoing chemotherapy. This study compared the bone mineral density (BMD) index of the mandible and hip hinge between patients who were undergoing chemotherapy or breast cancer, and fully edentulous Chinese patients without cancer over a period of 5 years.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">120 fully edentulous patients with an average age of 69 who had undergone mastectomy for grade two or three non-metastatic invasive breast ductal carcinoma. This was followed by administration of 5-fluorouracil, cyclophosphamide, and doxorubicin. The 118 fully edentulous cancer-free patients were included as a control group. The first assessment point was 6 months after chemotherapy treatment. The BMD and panoramic and side views of the mandible were measured by gamma-ray and the BMD of left hip hinge was measured using dual energy X-ray absorptiometry. The serum and urine level of bone-specific alkaline phosphatase (BAP), carboxyterminal cross-linked telopeptide of type I collagen (ICTP), as well as liver and renal function tests were determined. These examinations were performed annually for 5 years.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">The cancer patients demonstrated a statistically significant (p < 0.05) increase in bone resorption of mandible and hip, and an increase in BAP and ICTP levels when compared with the control group. Although data were collected annually there was no statistical significance for the first 3 years.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Breast cancer patients undergoing chemotherapy displayed significant resorption of mandibular bones compared with the healthy control, which might result in difficulties in fitting dentures, as it would cause pain and mucosal friction. Thus, concurrent therapy to decrease mandibular bone loss and special considerations in dentures are warranted for these patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Loo</LastName><ForeName>Wings T Y</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>The University Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>L J</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Mary N B</ForeName><Initials>MN</Initials></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Louis W C</ForeName><Initials>LW</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Min</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Opin Investig Drugs</MedlineTA><NlmUniqueID>9434197</NlmUniqueID><ISSNLinking>1354-3784</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>80168379AG</RegistryNumber><NameOfSubstance UI="D004317">Doxorubicin</NameOfSubstance></Chemical><Chemical><RegistryNumber>8N3DW7272P</RegistryNumber><NameOfSubstance UI="D003520">Cyclophosphamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>U3P01618RT</RegistryNumber><NameOfSubstance UI="D005472">Fluorouracil</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001862" MajorTopicYN="N">Bone Resorption</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003520" MajorTopicYN="N">Cyclophosphamide</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003824" MajorTopicYN="N">Denture, Complete</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004317" MajorTopicYN="N">Doxorubicin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005472" MajorTopicYN="N">Fluorouracil</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006615" MajorTopicYN="N">Hip</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008334" MajorTopicYN="N">Mandible</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009066" MajorTopicYN="N">Mouth, Edentulous</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="N">Osteoporosis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017755" MajorTopicYN="N">Prosthesis Fitting</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20374022</ArticleId><ArticleId IdType="doi">10.1517/13543781003727065</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Hong Kong</li></country></list><tree><noCountry><name sortKey="Cheung, Mary N B" sort="Cheung, Mary N B" uniqKey="Cheung M" first="Mary N B" last="Cheung">Mary N B. Cheung</name><name sortKey="Chow, Louis W C" sort="Chow, Louis W C" uniqKey="Chow L" first="Louis W C" last="Chow">Louis W C. Chow</name><name sortKey="Jin, L J" sort="Jin, L J" uniqKey="Jin L" first="L J" last="Jin">L J Jin</name><name sortKey="Wang, Min" sort="Wang, Min" uniqKey="Wang M" first="Min" last="Wang">Min Wang</name></noCountry><country name="Hong Kong"><noRegion><name sortKey="Loo, Wings T Y" sort="Loo, Wings T Y" uniqKey="Loo W" first="Wings T Y" last="Loo">Wings T Y. Loo</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D51 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002D51 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:20374022
|texte= Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:20374022" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |